The Role of Population-Based Observational Research in Bladder Cancer

被引：1
作者：
Robinson, Andrew G. [1 ]
Izard, Jason P. [1 ,2 ]
Booth, Christopher M. [1 ,3 ]
机构：
[1] Queens Univ, Dept Oncol, 25 King St West, Kingston, ON K7L 5P9, Canada
[2] Queens Univ, Dept Urol, Kingston, ON, Canada
[3] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada
来源：
BLADDER CANCER | 2015年 / 1卷 / 02期
关键词：
Population-based; effectiveness; utilization; bladder; metastatic; early; muscle invasive; chemotherapy; radiation-therapy; surgery;
D O I：
10.3233/BLC-150018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
While clinical trials have led to many advances in the treatment of bladder cancer, important gaps in knowledge persist. Population-based studies have made important contributions to what is known about bladder cancer and can contribute unique insights to practice and policy. In addition to evaluating effectiveness of interventions in routine practice, population-based studies can identify gaps between evidence and practice, and generate knowledge that cannot be gained from clinical trials. In this review we will highlight how population-based research has informed practice, policy, and the research agenda for bladder cancer.
引用
收藏
页码：123 / 131
页数：9
相关论文
共 63 条
  • [31] Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209
    Kitamura, H.
    Tsukamoto, T.
    Shibata, T.
    Masumori, N.
    Fujimoto, H.
    Hirao, Y.
    Fujimoto, K.
    Kitamura, Y.
    Tomita, Y.
    Tobisu, K.
    Niwakawa, M.
    Naito, S.
    Eto, M.
    Kakehi, Y.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (06) : 1192 - 1198
  • [32] Bladder Preservation for Localized Muscle-Invasive Bladder Cancer: The Survival Impact of Local Utilization Rates of Definitive Radiotherapy
    Kozak, Kevin R.
    Hamidi, Maryam
    Manning, Matthew
    Moody, John S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (02): : E197 - E204
  • [33] Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study
    Lamm, DL
    Blumenstein, BA
    Crissman, JD
    Montie, JE
    Gottesman, JE
    Lowe, BA
    Sarosdy, MF
    Bohl, RD
    Grossman, HB
    Beck, TM
    Leimert, JT
    Crawford, ED
    [J]. JOURNAL OF UROLOGY, 2000, 163 (04) : 1124 - 1129
  • [34] Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
    Leow, Jeffrey J.
    Martin-Doyle, William
    Rajagopal, Padma S.
    Patel, Chirayu G.
    Anderson, Erin M.
    Rothman, Andrew T.
    Cote, Richard J.
    Urun, Yuksel
    Chang, Steven L.
    Choueiri, Toni K.
    Bellmunt, Joaquim
    [J]. EUROPEAN UROLOGY, 2014, 66 (01) : 42 - 54
  • [35] Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-Operative Oncology Group
    Linardou, H
    Aravantinos, G
    Efstathiou, E
    Kalofonos, C
    Anagnostopoulos, A
    Deliveliotis, C
    Bafaloukos, D
    Dimopoulos, MA
    Bamias, A
    [J]. UROLOGY, 2004, 64 (03) : 479 - 484
  • [36] A PROSPECTIVE RANDOMIZED TRIAL COMPARING MVAC AND CISCA CHEMOTHERAPY FOR PATIENTS WITH METASTATIC UROTHELIAL TUMORS
    LOGOTHETIS, CJ
    DEXEUS, FH
    FINN, L
    SELLA, A
    AMATO, RJ
    AYALA, AG
    KILBOURN, RG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) : 1050 - 1055
  • [37] Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer
    Lohrisch, Caroline
    Paltiel, Charles
    Gelmon, Karen
    Speers, Caroline
    Taylor, Suzanne
    Barnett, Jeff
    Olivotto, Ivo A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (30) : 4888 - 4894
  • [38] Treatment of Nonmuscle Invading Bladder Cancer: Do Physicians in the United States Practice Evidence Based Medicine? The Use and Economic Implications of Intravesical Chemotherapy After Transurethral Resection of Bladder Tumors
    Madeb, Ralph
    Golijanin, Dragan
    Noyes, Katia
    Fisher, Susan
    Stephenson, Judith J.
    Long, Stacey R.
    Knopf, Joy
    Lyman, Gary H.
    Messing, Edward M.
    [J]. CANCER, 2009, 115 (12) : 2660 - 2670
  • [39] Multivariate analysis of the prognostic factors of primary superficial bladder cancer
    Millán-Rodríguez, F
    Chéchile-Toniolo, G
    Salvador-Bayarri, J
    Palou, J
    Vicente-Rodríguez, J
    [J]. JOURNAL OF UROLOGY, 2000, 163 (01) : 73 - 78
  • [40] The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011)
    Moynihan, Clare
    Lewis, Rebecca
    Hall, Emma
    Jones, Emma
    Birtle, Alison
    Huddart, Robert
    [J]. TRIALS, 2012, 13
1234567